A lateral flow test costing £1.99 has been approved for public sale in the UK.
The device, which has been produced by Everything Genetic, a genetic testing company based in Nantwich, Cheshire, has been approved in the UK under the UK Health Security Agency’s Medical Devices (Coronavirus Test Device Approvals) Regulations 2021 (CTDA) for continued sale.
James Price, Everything Genetic’s CEO, said: “I am delighted to announce that Everything Genetic’s COVID-19 (SARS-Cov-2) Antigen Test has been approved and added to the CTDA register. This is a significant milestone in our Covid testing service; a service that we have been providing since the start of the pandemic.
“With the Government announcing the end of access to free lateral flow tests, we look forward to ensuring that our customers continue to have access to this market-leading test at affordable prices coupled with a reliable delivery service and excellent customer care.”
The Antigen Test, which is the company’s first test to be added to the CTDA register, is suitable for use by people who are either symptomatic or asymptomatic.
According to Everything Genetic, the test boasts a clinical performance of 96.1 per cent sensitivity and 100 per cent specificity and results are provided within 15 minutes.
A single test kit will cost £1.99 and packs of 10’s and 20’s will start at £18.00 and £35.00 respectively.
“Although COVID tests won't be free after April 1, the importance and demand for using them to accurately gain a rapid insight into our health will continue for some time.” Price added.